l General Information |
Product Name | Bergenin |
General description | Bergenin is trihydroxybenzoic acid glycoside and the C-glycoside of 4-O-methyl gallic acid. |
Synonym | tetrahydro-2H-pyrano[3,2-c]isochromen-6-one; Corylopsin; Cuscutin; |
Purity | ≥98%(HPLC) | CAS Number | 477-90-7 |
Formula | C14H16O9 | Molecular Weight | 328.273 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White or Off-white solid |
Solubility(25℃) | DMSO | ≥50mg/mL |
Ethanol | Insoluble |
Water | Insoluble |
l Biological Information |
Biochem/Physiol Actions | Bergenin displays antinociceptive and anti-inflammatory properties, in addition to its use in folk medicines as a potent hepatoprotective agent. Bergenin acts by inhibiting the formation of interleukin 1beta and TNF-α, which suggests its potential use for controling inflammatory pain. |
l Packaging & Storage |
Packaging | 250mg; 1g |
Storage temp. | 0-5℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
